← Back to headlines
Eli Lilly's Position in Obesity Drug Market
An analysis questions whether Eli Lilly maintains its leadership in the $150 billion obesity drug market.
4 Aug, 15:15 — 4 Aug, 15:15
Sources
Showing 1 of 1 sources
An analysis questions whether Eli Lilly maintains its leadership in the $150 billion obesity drug market.
